• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

偶然发现的散发性和结节性硬化症相关淋巴管平滑肌瘤病的自然史。

Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis.

机构信息

Department of Health Sciences, Università Degli Studi di Milano, Milan, Italy; Respiratory Unit, ASST - Papa Giovanni XXIII Hospital, Bergamo, Italy.

Department of Health Sciences, Università Degli Studi di Milano, Milan, Italy; Respiratory Unit, ASST Santi Paolo e Carlo, Milan, Italy.

出版信息

Respir Med. 2020 Jul;168:105993. doi: 10.1016/j.rmed.2020.105993. Epub 2020 Apr 28.

DOI:10.1016/j.rmed.2020.105993
PMID:32469709
Abstract

Lymphangioleiomyiomatosis (LAM) is a rare disease affecting women in childbearing age. A sporadic form (S-LAM) affecting previously healthy women, and a form associated with Tuberous Sclerosis Complex (TSC-LAM) are described. Some data suggested that TSC-LAM could be a milder disease compared to S-LAM. To investigate whether the different disease behavior is real or due to overdiagnosis of screened TSC women, we compared the natural history of S-LAM and TSC-LAM in patients with incidental diagnosis. Clinical, and functional data from 52 patients (23 with S-LAM and 29 with TSC-LAM) were analysed. At diagnosis functional impairment was mild without differences between groups [FEV1 % pred was 97% (88-105) and 94% (82-106) in TSC-LAM and S-LAM, respectively, p = 0.125]. Patients with S-LAM had less renal angiomyolipoma, and lower VEGF-D serum levels than TSC-LAM. There was no difference in the baseline extent of pulmonary cysts on CT scan and no difference in yearly rate of functional decline between TSC-LAM, and S-LAM patients [e.g. yearly rate of decline of FEV1 % pred was -0.51 (-1.59-2.24) and -0.90 (-1.92--0.42) in TSC-LAM and S-LAM, respectively, p = 0.265]. In conclusion, the natural history of TSC-LAM and S-LAM, when a potential selection bias due to screening in the latter group is balanced, is similar. Our study suggests that the prevalence of S-LAM can be significantly underestimated due to a tendency to diagnosis more frequently patients with more severe impairment, without identifying several ones with asymptomatic disease.

摘要

淋巴管平滑肌瘤病(LAM)是一种罕见的疾病,影响育龄妇女。描述了一种散发性形式(S-LAM),影响以前健康的妇女,以及一种与结节性硬化症复合物(TSC-LAM)相关的形式。一些数据表明,与 S-LAM 相比,TSC-LAM 可能是一种较轻的疾病。为了研究不同的疾病行为是真实的还是由于对筛查的 TSC 妇女的过度诊断,我们比较了偶然诊断的 S-LAM 和 TSC-LAM 患者的自然病史。分析了 52 名患者(23 名 S-LAM 和 29 名 TSC-LAM)的临床和功能数据。在诊断时,功能损害较轻,两组之间无差异[FEV1%预测值分别为 TSC-LAM 和 S-LAM 的 97%(88-105)和 94%(82-106),p=0.125]。S-LAM 患者的肾血管平滑肌脂肪瘤较少,VEGF-D 血清水平较低。CT 扫描上肺囊肿的基线范围无差异,TSC-LAM 和 S-LAM 患者的功能下降年率也无差异[例如,FEV1%预测值的年下降率分别为 TSC-LAM 的-0.51(-1.59-2.24)和 S-LAM 的-0.90(-1.92--0.42),p=0.265]。总之,当平衡后者组中由于筛查而导致的潜在选择偏差时,TSC-LAM 和 S-LAM 的自然史是相似的。我们的研究表明,由于倾向于诊断更多功能损害更严重的患者,而没有发现几个无症状的患者,S-LAM 的患病率可能被严重低估。

相似文献

1
Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis.偶然发现的散发性和结节性硬化症相关淋巴管平滑肌瘤病的自然史。
Respir Med. 2020 Jul;168:105993. doi: 10.1016/j.rmed.2020.105993. Epub 2020 Apr 28.
2
Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex.结节性硬化症患者中淋巴管平滑肌瘤病(LAM)的患病率及临床特征
Am J Respir Crit Care Med. 2001 Aug 15;164(4):669-71. doi: 10.1164/ajrccm.164.4.2101154.
3
[Sporadic Lymphangioleiomyomatosis (sLAM) and Tuberous Sclerosis Complex (TSC) - Pulmonary Manifestations].[散发性淋巴管平滑肌瘤病(sLAM)和结节性硬化症(TSC)——肺部表现]
Pneumologie. 2017 Feb;71(2):86-95. doi: 10.1055/s-0042-111522. Epub 2016 Sep 1.
4
Lymphangioleiomyomatosis screening in women with tuberous sclerosis.结节性硬化症女性的淋巴管平滑肌瘤病筛查。
Chest. 2013 Aug;144(2):578-585. doi: 10.1378/chest.12-2813.
5
Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.日本结节性硬化症患者的淋巴管平滑肌瘤病和多灶性微小结节性肺细胞增生症
Respir Investig. 2016 Jan;54(1):8-13. doi: 10.1016/j.resinv.2015.06.003. Epub 2015 Oct 29.
6
Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.结节性硬化症患者的淋巴管平滑肌瘤病:国家中心审计。
Orphanet J Rare Dis. 2024 Mar 26;19(1):137. doi: 10.1186/s13023-024-03115-y.
7
Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec: Prevalence and Health-care Utilization.魁北克的淋巴管平滑肌瘤病和结节性硬化症复合体:患病率与医疗保健利用情况
Chest. 2015 Aug;148(2):444-449. doi: 10.1378/chest.14-3095.
8
Tuberous sclerosis complex presenting as pulmonary lymphangioleiomyomatosis--a clinicoradiological diagnosis.以肺淋巴管平滑肌瘤病形式出现的结节性硬化症——一种临床放射学诊断
Pan Afr Med J. 2015 Mar 6;20:207. doi: 10.11604/pamj.2015.20.207.5490. eCollection 2015.
9
Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features.散发性淋巴管平滑肌瘤病与结节性硬化症合并淋巴管平滑肌瘤病:CT特征比较
Radiology. 2007 Jan;242(1):277-85. doi: 10.1148/radiol.2421051767. Epub 2006 Nov 14.
10
Women with TSC: Relationship between Clinical, Lung Function and Radiological Features in a Genotyped Population Investigated for Lymphangioleiomyomatosis.患有结节性硬化症的女性:针对淋巴管平滑肌瘤病进行基因分型的人群中临床、肺功能与放射学特征之间的关系
PLoS One. 2016 May 12;11(5):e0155331. doi: 10.1371/journal.pone.0155331. eCollection 2016.

引用本文的文献

1
Clinical, tomographic and functional comparison of sporadic and tuberous sclerosis complex-associated forms of lymphangioleiomyomatosis: a retrospective cohort study.散发性与结节性硬化症相关型淋巴管平滑肌瘤病的临床、断层扫描及功能比较:一项回顾性队列研究
ERJ Open Res. 2024 Mar 4;10(2). doi: 10.1183/23120541.00759-2023. eCollection 2024 Mar.
2
Tuberous sclerosis complex associated lymphangioleiomyomatosis.结节性硬化症相关淋巴管平滑肌瘤病
QJM. 2023 Oct 23;116(10):873-874. doi: 10.1093/qjmed/hcad125.
3
Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis.
预测未经治疗的淋巴管平滑肌瘤病患者的个体化肺病进展。
Chest. 2023 Jun;163(6):1458-1470. doi: 10.1016/j.chest.2022.12.027. Epub 2023 Jan 4.
4
Tuberous sclerosis complex for the pulmonologist.肺科医生须知的结节性硬化症。
Eur Respir Rev. 2021 Aug 3;30(161). doi: 10.1183/16000617.0348-2020. Print 2021 Sep 30.
5
Exploring the Role of Matrix Metalloproteinases as Biomarkers in Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex. A Pilot Study.探索基质金属蛋白酶作为散发性淋巴管平滑肌瘤病和结节性硬化症生物标志物的作用:一项初步研究。
Front Med (Lausanne). 2021 Apr 26;8:605909. doi: 10.3389/fmed.2021.605909. eCollection 2021.
6
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly.2019年欧洲呼吸学会国际大会:间质性肺疾病专题会议亮点
ERJ Open Res. 2020 Oct 5;6(4). doi: 10.1183/23120541.00143-2020. eCollection 2020 Oct.